Aquestive Therapeutics, Inc.Aquestive Therapeutics, Inc.Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc.

No trades
See on Supercharts

Price target

9.560.000.00%
The 8 analysts offering 1 year price forecasts for AQST have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to AQST in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


AQST EPS for the last quarter is −0.13 USD despite the estimation of −0.12 USD. In the next quarter EPS is expected to reach −0.13 USD. Track more of Aquestive Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Aquestive Therapeutics, Inc. revenue is expected to reach ‪13.21 M‬ USD. Check out Aquestive Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, AQST price target is 9.56 USD with a max estimate of 15.00 USD and a min estimate of 5.50 USD. Check if this forecast comes true in a year, meanwhile watch Aquestive Therapeutics, Inc. stock price chart and keep track of the current situation with AQST news and stock market news.
We've gathered opinions of 8 analysts rating AQST stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.